H igh blood pressure (BP) is a major public health challenge worldwide because of its high prevalence and associated mortality and morbidity. 1, 2 As a complex trait, BP is influenced by both genetic and environmental factors as well as their interactions. Sodium intake has been demonstrated as an important environmental determinant of hypertension and varies greatly within and across populations. 3, 4 Numerous genome-wide association studies have identified robust associations between genomic loci and BP. [5] [6] [7] [8] [9] However, these findings explain only a small proportion of the estimated heritability of this complex phenotype. 10 Because the marginal effects of variants modified by environmental factors may be missed by traditional single-marker analyses, scientists postulate that additional genetic factors may be detected through the analysis of gene-environment interactions. Relatedly, an important inter-relationship of sodium and genetic factors on BP has been demonstrated through the identifications of genes responsible for Mendelian forms of hypertension, with the vast majority of recognized genes exerting their effects via renal sodium handling. 11 Because genes may modify the effect of sodium on BP, examination of gene-dietary sodium intake interactions may help Abstract-We performed genome-wide analyses to identify genomic loci that interact with sodium to influence blood pressure (BP) using single-marker-based (1 and 2 df joint tests) and gene-based tests among 1876 Chinese participants of the Genetic Epidemiology Network of Salt-Sensitivity (GenSalt) study. Among GenSalt participants, the average of 3 urine samples was used to estimate sodium excretion. Nine BP measurements were taken using a random zero sphygmomanometer. A total of 2.05 million single-nucleotide polymorphisms were imputed using Affymetrix 6.0 genotype data and the Chinese Han of Beijing and Japanese of Tokyo HapMap reference panel. Promising findings (P<1.00×10 -4 ) from GenSalt were evaluated for replication among 775 Chinese participants of the Multi-Ethnic Study of Atherosclerosis (MESA). Single-nucleotide polymorphism and gene-based results were meta-analyzed across the GenSalt and MESA studies to determine genome-wide significance. The 1 df tests identified interactions for UST rs13211840 on diastolic BP (P=3.13×10 -9 ). The 2 df tests additionally identified associations for CLGN rs2567241 (P=3.90×10 -12 ) and LOC105369882 rs11104632 (P=4.51×10 -8 ) with systolic BP. The CLGN variant rs2567241 was also associated with diastolic BP (P=3.11×10 -22 ) and mean arterial pressure (P=2.86×10 -15 ). Genome-wide gene-based analysis
Furthermore, gene-based analyses, which test the joint contributions of single-nucleotide polymorphisms (SNPs) with individually modest effects, may have higher power to identify BP loci. 13, 14 Although the examination of gene-sodium interactions in single-marker-based and gene-based analyses could provide important insights into the molecular mechanisms underlying BP regulation, there has been a paucity of research in this area.
The objective of the current analysis was to identify novel genetic variants and genes influencing BP regulation by conducting genome-wide SNP-based and gene-based genesodium interaction analyses on BP among 1876 Chinese participants of the Genetic Epidemiological Network of SaltSensitivity (GenSalt) study.
Methods

Study Population
GenSalt is a family-based dietary intervention study designed to identify susceptibility genes that influence BP responses to environmental risk factors for hypertension in human populations. The study includes 1906 Han Chinese participants aged ≥16 years from 633 families recruited from 6 study sites in rural, north China. 15 In the current study, genotypes, BP, and covariates at baseline were available for a total of 1876 participants (98.4%).
Genotyping and Genotype Imputation
A total of 868 158 autosomal SNPs across the entire genome were genotyped using the Affymetrix 6.0 platform for each participant. Quality control excluded SNPs with Hardy-Weinberg equilibrium P<1×10 -6 , missing rate >25% or minor allele frequency (MAF) <1%. In addition, PLINK 16, 17 and PedCheck 18 were used to identify and correct any non-Mendelian inheritance errors. After quality control, a total of 820 017 genotyped SNPs remained for genotype imputation. Imputation of 2 416 663 SNPs from the HapMap release 22 build 36 CHB+JPT samples was conducted using MACH software. 19 After imputation, SNPs with r 2 <0.30, MAF<1%, or Hardy-Weinberg equilibrium P<1×10 -6 were removed, and a total of 2 216 774 SNPs, with fractional values ranging from 0 to 2, remained for the analysis.
Urinary Sodium and Covariate Measurement
Dietary sodium intake was measured from 24-hour urinary sodium level. During the 3-day baseline examination, each GenSalt participant collected 3 urine samples, including one 24-hour urine sample and 2 overnight urine samples. Among a random sample of 238 participants, 24-hour urine samples were collected in 2 containers: one for daytime and the other for overnight. Using this random sample, an equation was generated to estimate 24-hour urinary sodium level from the overnight urine sample. This equation was applied to the remaining overnight urine samples to estimate 24-hour urinary sodium levels among all study participants. The mean of 1 measured 24-hour urinary sodium level and 2 estimated 24-hour urinary sodium levels was used in the current analysis.
Demographic variables, including age, sex, and medication use were collected using standard questionnaires by trained study staff. Body weight and height were measured twice during the baseline examination with the participants in light indoor clothing without shoes. Body mass index was calculated as kilograms per meters squared.
BP Measurement and Imputation
BP was measured 3× at the same time each morning during the 3-day baseline examination by trained and certified observers using a random zero sphygmomanometer according to a standard protocol. For participants taking antihypertensive medications, BP was imputed by adding 10 mm Hg to systolic BP (SBP) and 5 mm Hg to diastolic BP (DBP). 20 After imputation, the mean of the 9 BP measures was used in the current analysis. Mean arterial pressure (MAP) was calculated as SBP/3+2DBP/3, and pulse pressure was calculated as SBP−DBP.
Replication Study and Genotype Imputation
We attempted to replicate promising GenSalt findings (P<1×10 -4 ) among Chinese participants of the Multi-Ethnic Study of Atherosclerosis (MESA). MESA participants were recruited between July 2000 and August 2002 from 6 field centers around the United States. Participants were aged 45 to 84 and free of cardiovascular diseases at the baseline examination. Phenotype and Affymetrix 6.0 genotype data from MESA participants were made publicly available through the NCBI's database of Genotypes and Phenotypes (dbGaP) and were downloaded for the current analysis. Among 777 Chinese MESA participants, genotype, urinary sodium, BP, and all covariables at baseline were available for 775 (99.7%) participants. Similar to GenSalt, we imputed BP for participants taking antihypertensive medication by adding 10 and 5 mm Hg to SBP and DBP, respectively. Because sodium was measured from spot urine using baseline urine samples, 24-hour urine sodium was estimated using Tanaka equation. 21 A total of 909 622 autosomal SNPs across the entire genome were genotyped using the Affymetrix 6.0 platform for each participant. We excluded SNPs with Hardy-Weinberg Equilibrium P<1×10 -6 , missing rate >5%, and MAF<1%. Minimac software was used to perform targeted imputation of the 3-Mb region surrounding each identified SNP based on the ALL ancestry panel from the 1000G Phase I Integrated Release Version 3 Haplotypes, which contains haplotypes of 1092 individuals of all ethnic background. After imputation, SNPs with r 2 <0.30, MAF<1%, or Hardy-Weinberg equilibrium P<1×10 -6 were removed.
Statistical Analysis
Single-Marker Analysis
To accommodate familial relationships in both GenSalt (discovery) and MESA (replication) studies, mixed-effect models were used to examine SNP-sodium interactions on BP, after adjustment for age, sex, and body mass index. Principal components analysis revealed population substructure in MESA (but not in GenSalt). Therefore, ancestry was also accounted for in MESA by adjusting for the first 3 principal components. Both 1 df interaction and 2 df joint tests were explored. 22 Lead SNPs (defined as the most significant SNP at a locus) with interaction term P<1.0×10 -4 (for the 1 df test) or joint P<1.0×10 -4 (for the 2 df test) after genomic control in the discovery stage analyses were further evaluated for replication in Chinese MESA participants. For the 1 df interaction test, inverse-varianceweighted meta-analysis was conducted to combine results from GenSalt and MESA using METAL software. 23 For the 2 df joint test, meta-analysis was performed using methods described by Manning et al, 24 which were implemented in METAL software 23 with a patch source code provided by Manning et al. 24 After ensuring that the effect direction of interaction terms was consistent, SNPs with replication stage P<0.05 and meta-analysis P<5.0×10 -8 were considered significant for the 1 df interaction test. SNPs with consistent effect directions in the main effect and interaction term, replication stage P<0.05, and meta-analysis P<5.0×10 -8 were considered significant for the 2 df joint test.
Gene-Based Analysis
SNPs within the 5-kb flanking regions of a gene were first mapped to the gene according to physical position. SNPs within 5-kb flanking regions of 2 genes were assigned to both genes. P values of both 1 df interaction and 2 df joint tests in single-marker analyses were used to generate gene-based P values using the extended Simes procedure (GATES) method. 13 Genes with P<1.0×10 -4 in the discovery stage analysis in GenSalt were further evaluated for replication among Chinese MESA participants. Among MESA participants, SNPs from promising genes were tested for SNP-sodium interactions by guest on August 25, 2017 http://hyper.ahajournals.org/ Downloaded from using methods described in the above single-marker analysis, and P values of these SNPs were again used to generate gene-based P values using the GATES method. 13 Fisher method was applied to combine gene-based P values across GenSalt and MESA. 25 Genes with replication stage P<0.05 and combined P<2.5×10 -6 (correcting for ≈20 000 genes across the genome: 0.05/20 000=2.5×10 -6 ) were considered significant.
Results
Characteristics of both GenSalt participants and Chinese MESA participants are shown in Table 1 . MESA participants were older, had lower urinary sodium level, and had a higher proportion of hypertension. Participants in both studies had optimal BP levels.
In ; and Meta-analysis, P=2.86×10 -15 ). Regional association plots for the 3 novel loci (CLGN, UST, and LOC105369882) with genome-wide significance in the meta-analyses are presented in the Figure. Although some loci (eg, rs2567241) achieved genome-wide significance for >2 interactions, only 1 regional association plot is shown for each loci using the most significant interaction.
Discovery 
Discussion
In the first genome-wide gene-sodium interaction analysis conducted in the Chinese population, we identified consistent interactions of UST rs13211840 at 6q25.1 with sodium intake on the DBP phenotype using both 1 df and 2 df interaction tests. The 2 df test also revealed associations of novel LOC105369882 rs11104632 variant at 12q21.32 with SBP, whereas the novel CLGN rs2567241 variant was associated with SBP, DBP, and MAP in the 2 df test. Furthermore, genome-wide gene-based analysis of both 1 df and 2 df interaction tests identified MKNK1 at 1p33, C2orf80 at 2q34, EPHA6 at 3q11.2, SCOC-AS1, SCOC, CLGN, and MGAT4D at 4q31.1, ARHGAP42 at 11q22.1, and LINC01478 at 18q12.3 that were associated with at least 1 BP phenotype.
Novel UST, LOC105369882 variants rs13211840 and rs11104632, respectively, showed significant interactions with sodium on BP in the current analysis. The UST signal was consistent across the 1 df and 2 df interaction tests, whereas the LOC105369882 locus was identified only in the 2 df test. Although the potential role of UST in BP is unclear, other genes at this locus represent interesting BP candidates. For example, the SASH1 gene has been associated with thyroid function 26 and suggestively associated with responses to rate control therapy among patients with atrial fibrillation. 27 A more recent study indicated that the SASH1 gene may interact with smoking on SBP. 28 Although the role of LOC105369882 in BP is unclear, another gene at this locus, CEP290, is potentially relevant to BP regulation, 29 with mutations of this gene shown to associate with many disease phenotypes characterized by renal impairment. 30, 31 Considering the important roles of the thyroid in BP regulation and kidney in sodium filtration, both loci warrant further studies to identify the true causal variant(s). Association of CLGN at 4q28.3-q31.1 with BP phenotypes was identified consistently in the single-marker-based and gene-based analyses. In single-marker analysis, 3 genomewide significant exonic missense mutations were identified at the CLGN locus, including lead CLGN SNP rs2567241 along with 2 other SNPs, rs358304 of CLGN1 and rs2175563 of nearby SCOC. Although the physiological relevance of the CLGN1 and SCOC genes with BP regulation is unclear, additional studies are warranted to determine the potential functional relevance of these promising single-marker findings. In gene-based analysis, CLGN1 represented one of a cluster of genes including SCOC-AS1, SCOC, and MGAT4D, which interacted with sodium to influence BP. It is unlikely that they are all causally relevant to BP regulation. Future works are warranted to delineate the causal genes involved in BP regulation at this locus.
Genome-wide gene-based analysis also identified novel genes MKNK1 at 1p33, C2orf80 at 2q34, EPHA6 at 3q11.2, CASP4 at 11q22.3, and LINC01478 at 18q12.3, as well as previously reported BP gene ARHGAP42 at 11q22.1.
5,6
MNK1 encodes a Ser/Thr protein kinase that interacts with extracellular signal-regulated kinase 1 and p38 mitogenactivated protein kinase, 32 a pathway that is involved in BP regulation through norepinephrine and angiotensin II. 33 Despite its potential biological relevance, our study provides the first evidence that the MKNK1 gene is involved in BP regulation in human populations. The CASP4 gene encodes a protein in the cysteine-aspartic acid protease family and plays an import role in inflammation and innate immunity through the activation of caspase-1. 34 Pathophysiological studies showed that the overexpression of the CASP4 gene was involved in the loss of proximal tubules and renal injury in nephropathic cystinosis patients. 35 Considering kidney's key roles in sodium filtration and reabsorption, future studies of CASP4 genes are warranted to identify the causal variant(s). Previous studies have identified associations of the EPHA6 gene with obesity-related traits. 36 The EPHA6 locus also includes the ARL6 gene, which encodes ADPribosylation factor-like 6. Mutations of the ARL6 gene cause Bardet-Biedl syndrome, 37 a heterogeneous disorder that increases the risk of hypertension and diabetes mellitus. 38 Gene-based analysis also revealed novel associations of C2orf80 at 2q34, and LINC01478 at 18q12.3. However, the mechanisms linking these genes to BP regulation are unclear. In aggregate, the identification of these 6 novel loci in gene-based analyses highlights the power and potential utility of gene-based analysis in genomic study.
Our study has several strengths. First, stringent quality control methods were used in measuring genotype, phenotype, and covariate data for both the discovery and the replication stage samples. This can reduce phenotype measurement error and increase statistical power in identifying both single SNPs and genes underlying BP regulation. Second, because we limited our analysis exclusively to Chinese participants, population stratification should be minimized. Finally, a total of 9 BPs were measured using a random zero sphygmomanometer at the same time during the 3-day baseline examination in the discovery stage. This can greatly reduce measurement error of BP and increase statistical power to detect genetic variants for BP. Certain limitations should also be acknowledged. The MESA replication study has a smaller sample size than that of GenSalt, potentially limiting our ability to replicate and identify important genesodium interactions. In addition, 24-hour urinary sodium was estimated from spot urine among the Chinese MESA participants using Tanaka's equation. Although Tanaka equation has been widely validated, 39-41 there might be some measurement error that could reduce statistical power to replicate genetic loci identified in GenSalt participants, increasing false-negative findings. MESA had a higher proportion of participants taking antihypertensive medication. We imputed BP by adding 10 and 5 mm Hg to SBP and DBP, respectively. Although this approach is widely applied to genetic studies of BP, 6, 7, 9 any resulting inaccuracy may dilute associations between genetic factors and BP. Furthermore, additional factors such as age and urbanization level differ between the GenSalt and MESA samples. If these factors influence genesodium interactions on BP, our power to detect (or replicate) SNP-BP associations could again be reduced. Although the SNPs identified in GenSalt have low MAFs, the findings were verified through replication in MESA participants. Still, future replication studies with larger sample size, more homogeneous populations and better measurement of urinary sodium levels are warranted.
Perspectives
In the first genome-wide gene-sodium interaction analyses of BP in a Chinese population, which included both singlemarker-based and gene-based analyses, we identified 9 novel loci that interacted with dietary sodium intake on BP phenotypes. In addition to the 1 novel locus identified through the traditional 1 df single-marker interaction analysis (UST rs13211840), another 2 loci were documented using the 2 df test (CLGN rs2567241 and LOC105369882 rs11104632) . Gene-based analysis provided consistent support for the CLGN gene (plus several other genes clustered at the CLGN locus) and identified an additional 5 novel genes, including MKNK1, C2orf80, EPHA6, CASP4, and LINC01478. In comparison with the previous large-scale genome-wide association studies meta-analyses of BP conducted in East Asians, the current study was able to robustly identify several novel loci with a relatively small sample size. Such findings highlight the importance of examining gene-sodium interactions and conducting gene-based analysis to identify genomic mechanisms influencing BP. Furthermore, these findings contribute to understanding the mechanisms of BP regulation. Sequencing along with functional studies are needed to help delineate causal variants underlying the strong signals identified here.
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